Why Oxford-AstraZeneca COVID Vaccine Could Be More Important Than Pfizer and Moderna's in Ending Pandemic Published Nov 23, 2020 at 11:01 AM EST Updated Nov 28, 2020 at 7:17 AM EST By Aristos Georgiou ...

An experimental coronavirus vaccine developed by Oxford University and drug manufacturer AstraZeneca appears to be up to 90% effective, the two partners announced Monday. The encouraging results ...

Morocco's health ministry on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, Health Minister Khalid Ait Taleb said. Morocco had announced ...

AstraZeneca and Oxford University announced that late-stage trials have shown that one of its vaccine candidate's dosing regimens may be around 90 percent effective.

AstraZeneca and the University of Oxford announced Monday that late-stage trials show their COVID-19 vaccine was up to 90% effective in preventing the disease.

Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient ...

Last month, Oxford University researchers released results from its Phase 3 trial, including one surprising detail: Some trial volunteers received a lower first dose of the vaccine, but appeared ...

AstraZeneca and Oxford University have started developing a version of their coronavirus shot that targets omicron, as researchers study the efficacy of existing vaccines against the latest ...

Oxford University and AstraZeneca's Covid-19 vaccine became the first to have its Phase 3 trial published in a peer-reviewed paper, the Lancet medical journal.

A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday Nov. 23, 2020.